speb/financial-data huggingface dataset:
INPHI.AS income_statement (annual, 2024-12-31) — +Total Revenue: 18021000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Accounts Payable: 1830000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3513000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -3989000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -3989000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 6755000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -245000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -245000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 693000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 693000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 344000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 344000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Basic Average Shares: 933371000.00
INPHI.AS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 929378000.00
INPHI.AS income_statement (annual, 2024-12-31) — Basic EPS: -0.75
INPHI.AS income_statement (quarterly, 2024-12-31) — Basic EPS: -0.36
INPHI.AS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1869000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Capital Expenditure: -676000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -558000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1073000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 1073000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Capital Stock: 188000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2401000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2401000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Cash Equivalents: 1946000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 1946000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Cash Financial: 455000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Cash Financial: 455000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -497000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -573000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 1569000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Cash Flow From Discontinued Operation: -13000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Account Payable: -583000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Inventory: 230000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -51000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 316000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Payable: -583000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -583000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Receivables: -6000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Change In Working Capital: -94000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -1000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Changes In Cash: 487000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Common Stock: 188000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -1000000.00
INPHI.AS cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -1000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 12006000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
INPHI.AS cash_flow (annual, 2024-12-31) — Common Stock Payments: -411000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Construction In Progress: 271000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 271000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Cost Of Revenue: 10248000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1782000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Assets: 10022000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 219000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 219000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Debt: 224000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 443000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 1699000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 1699000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Liabilities: 8144000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Current Provisions: 1977000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Deferred Income Tax: 964000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Deferred Tax: 964000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Depreciation: 696000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1389000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1389000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 66000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 66000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Diluted Average Shares: 933371000.00
INPHI.AS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 929378000.00
INPHI.AS income_statement (annual, 2024-12-31) — Diluted EPS: -0.75
INPHI.AS income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.36
INPHI.AS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -702000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Dividend Received Cfo: 8000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Dividends Payable: 0.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 0.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 25000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 25000000.00
INPHI.AS income_statement (annual, 2024-12-31) — EBIT: 460000000.00
INPHI.AS income_statement (annual, 2024-12-31) — EBITDA: 1849000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -124000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 126000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 45000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — End Cash Position: 2401000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Financial Assets: 8000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Financial Assets: 8000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 288000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 288000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Financing Cash Flow: -496000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Finished Goods: 1439000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Finished Goods: 1439000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: 2014000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Free Cash Flow: 893000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 13000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 3000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -25000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1925000000.00
INPHI.AS income_statement (annual, 2024-12-31) — General And Administrative Expense: 582000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Goodwill: 10383000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 13366000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 3758000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 3758000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Gross PPE: 6442000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Gross PPE: 6442000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Gross Profit: 7773000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 69000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Income Tax Payable: 71000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Interest Expense: 337000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 337000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Interest Income: 79000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 79000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -261000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Interest Payable: 83000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Interest Payable: 83000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Interest Received Cfo: 83000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Inventory: 3198000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Invested Capital: 18424000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -573000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 632000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Investments And Advances: 889000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 257000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
INPHI.AS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 710000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Land And Improvements: 1151000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 1151000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Leases: 1462000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Leases: 1462000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Line Of Credit: 92000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 92000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 854000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 854000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Long Term Debt: 6194000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 7048000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 710000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -763000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 257000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Long Term Provisions: 996000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1790000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1790000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Minority Interest: 37000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Minority Interests: -3000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 118000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -411000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Net Debt: 4017000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Income: -702000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -702000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -840000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 142000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -702000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -844000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -840000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -698000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -118000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Interest Income: -257000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -28000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -83000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -53000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -257000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Net PPE: 2453000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 13000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -30000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -1360000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 208000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 1916000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 512000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 431000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1916000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 81000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Normalized EBITDA: 1858000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Normalized Income: -837322000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 1569000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Operating Gains Losses: 107000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Operating Income: 513000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Operating Revenue: 17667000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 925009074.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Current Assets: 1000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 132000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 211000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -89000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Equity Interest: -101000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Other Gand A: 582000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Other Income Expense: -133000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2983000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Inventories: 1000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Other Inventories: 1000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 290000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 123000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 167000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Other Operating Expenses: 445000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Payable: 16000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Other Payable: 16000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Properties: 1768000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Other Properties: 1768000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Receivables: 483000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Other Receivables: 483000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 2000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 2000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Payables: 2032000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3814000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 238000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 238000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Pretax Income: 123000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Properties: 0.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
INPHI.AS cash_flow (annual, 2024-12-31) — Purchase Of Business: -8000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -118000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -123000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Raw Materials: 1344000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Raw Materials: 1344000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Receivables: 4115000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 10248000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1389000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -763000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -411000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Research And Development: 1747000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Retained Earnings: 3650000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Sale Of Business: 126000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Sale Of Investment: 95000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Sale Of PPE: 13000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 4486000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Selling General And Administration: 5068000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Share Issued: 939939384.00
INPHI.AS income_statement (annual, 2024-12-31) — Special Income Charges: 16000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 96000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 12006000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Tangible Book Value: -1360000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -2322000.00
INPHI.AS income_statement (annual, 2024-12-31) — Tax Provision: 963000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.26
INPHI.AS balance_sheet (annual, 2024-12-31) — Taxes Receivable: 94000000.00
INPHI.AS cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -173000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Assets: 28976000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Capitalization: 18200000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Debt: 7491000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 12043000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Total Expenses: 17508000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 16933000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 18955000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 8789000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 529000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Total Other Finance Cost: -1000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 186000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Total Unusual Items: -9000000.00
INPHI.AS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -9000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 119000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 119000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 14930310.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 14930310.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Treasury Stock: 411000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Work In Process: 414000000.00
INPHI.AS balance_sheet (quarterly, 2024-12-31) — Work In Process: 414000000.00
INPHI.AS balance_sheet (annual, 2024-12-31) — Working Capital: 1878000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1694000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — +Total Revenue: 4097000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1830000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3387000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 6700000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 944671000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.08
INPHI.AS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2401000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -161000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -115000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 188000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1193000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1195000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -48000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -159000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -931000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Cash Flow From Discontinued Operation: -10000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -165000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Inventory: -248000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -25000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -1066000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Payable: -165000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -165000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 160000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1344000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1148000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Common Stock: 188000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 11697000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2248000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1311000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Assets: 8669000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Debt: 513000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 513000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1771000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1771000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 6757000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 874000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 27000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Deferred Tax: 27000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Depreciation: 276000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 276000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 276000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 3000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 957743000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.08
INPHI.AS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 76000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Dividend Received Cfo: 8000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — EBIT: 186000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — EBITDA: 462000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -1000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 1000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -60000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — End Cash Position: 1193000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 14000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -48000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: 1577000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1094000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1489000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 161000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Goodwill: 10090000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 12977000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Gross Profit: 1849000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 48000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 42000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Interest Expense: 82000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 82000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Interest Income: 33000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 33000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -61000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 30000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Inventory: 3331000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 19266000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -157000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 600000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 847000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 247000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 16000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 7056000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7056000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 9000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 247000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 988000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 31000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Minority Interests: 4000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -10000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Net Debt: 6376000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Income: 76000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 76000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 78000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -6000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 76000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 82000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 78000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 72000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -46000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Interest Income: -49000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 10000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -47000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 9000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -49000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -1000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 2000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2389000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 2000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -56000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -1280000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 218000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 1916000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 491000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 412000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1916000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 79000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 462000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Normalized Income: 82000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -933000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -1000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Operating Income: 155000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Operating Revenue: 4097000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 925084000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 618000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 513000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 416000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 6000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Other Gand A: 161000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Other Income Expense: -1000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2887000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 92000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 137000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 30000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -11000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 2000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Payables: 1872000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3183000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Pretax Income: 104000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -10000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -46000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -17000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Receivables: 3477000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2248000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 276000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -63000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Research And Development: 457000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 3728000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 27000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 2000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1087000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1248000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Share Issued: 940014310.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 7000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -63000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 48000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 11697000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -1280000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Tax Provision: 27000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 90000000.00
INPHI.AS cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -86000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Assets: 27167000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 18753000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Debt: 7569000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 11728000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Total Expenses: 3942000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 15439000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 18498000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 8682000000.00
INPHI.AS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 154000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 42000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 114000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 14930310.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 409000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Unrealized Gain Loss: -94000000.00
INPHI.AS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1912000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1610000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — +Total Revenue: 4338000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1752000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 3254000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 7135000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 194000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 946332000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.25
INPHI.AS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1193000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -159000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -135000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 193000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1822000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1824000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -295000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 546000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -226000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 387000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -17000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Inventory: -120000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 18000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -73000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Payable: -17000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -17000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -33000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -225000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 708000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Common Stock: 193000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -295000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 10379000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2327000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1422000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Assets: 9063000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Debt: 1244000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1244000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1575000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1575000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 7201000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Current Provisions: 758000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 95000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Deferred Tax: 95000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Depreciation: 266000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 266000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 266000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 7000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 956676000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.25
INPHI.AS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 240000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 3000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 33000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — EBIT: 417000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — EBITDA: 683000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -6000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 6000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -79000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — End Cash Position: 1822000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Financial Assets: 18000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 268000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 546000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 434000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 228000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 347000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 155000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Goodwill: 9363000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 12075000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Gross Profit: 2011000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 99000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 58000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Interest Expense: 80000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 80000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Interest Income: 23000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 23000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -89000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 13000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Inventory: 3232000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 18805000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -225000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 462000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 686000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 224000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 1019000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 7182000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 7182000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 1010000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 224000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 957000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Minority Interest: 29000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Minority Interests: -1000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 1000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Net Debt: 6604000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Income: 240000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 240000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 242000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -2000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 240000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 242000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 242000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 240000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -24000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Interest Income: -57000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -69000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 840000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 1010000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -57000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 1000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Net PPE: 2260000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 2000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -170000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1696000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 250000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 1798000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 488000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 412000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1798000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 76000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 94000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 683000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Normalized Income: 242000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 387000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 7000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Operating Income: 401000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Operating Revenue: 4338000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 950574479.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 581000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1244000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 359000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 25000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -1000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Other Gand A: 155000000.00
INPHI.AS income_statement (quarterly, 2025-06-30) — Other Income Expense: -6000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2712000000.00
INPHI.AS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 78000000.00
INPHI.AS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 135000000.00